Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111642913 | 11164291 | 3 | F | 2014 | 20160712 | 20150604 | 20160718 | EXP | US-JNJFOC-20150519201 | JANSSEN | 73.70 | YR | E | M | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111642913 | 11164291 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 111642913 | 11164291 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | TABLET | |||||||
| 111642913 | 11164291 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | 20 | MG | TABLET | |||||
| 111642913 | 11164291 | 4 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | TABLET | |||||||
| 111642913 | 11164291 | 5 | SS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 0 | TABLET | |||||||
| 111642913 | 11164291 | 6 | PS | XARELTO | RIVAROXABAN | 1 | Oral | Y | N | UNKNOWN | 202439 | 20 | MG | TABLET | |||||
| 111642913 | 11164291 | 7 | SS | COUMADIN | WARFARIN SODIUM | 1 | Unknown | U | 0 | UNSPECIFIED | |||||||||
| 111642913 | 11164291 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 9 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 10 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 11 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 111642913 | 11164291 | 14 | C | METOLAZONE. | METOLAZONE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111642913 | 11164291 | 1 | Thrombosis prophylaxis |
| 111642913 | 11164291 | 2 | Thrombosis prophylaxis |
| 111642913 | 11164291 | 3 | Cerebrovascular accident prophylaxis |
| 111642913 | 11164291 | 4 | Cerebrovascular accident prophylaxis |
| 111642913 | 11164291 | 5 | Atrial fibrillation |
| 111642913 | 11164291 | 6 | Atrial fibrillation |
| 111642913 | 11164291 | 7 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111642913 | 11164291 | LT |
| 111642913 | 11164291 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111642913 | 11164291 | Acute kidney injury | |
| 111642913 | 11164291 | Haematoma | |
| 111642913 | 11164291 | Internal haemorrhage | |
| 111642913 | 11164291 | Liver injury | |
| 111642913 | 11164291 | Post procedural haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111642913 | 11164291 | 1 | 20131217 | 20140220 | 0 | |
| 111642913 | 11164291 | 2 | 20140801 | 0 | ||
| 111642913 | 11164291 | 3 | 20131217 | 20140220 | 0 | |
| 111642913 | 11164291 | 4 | 20140801 | 0 | ||
| 111642913 | 11164291 | 5 | 20140801 | 0 | ||
| 111642913 | 11164291 | 6 | 20131217 | 20140220 | 0 | |
| 111642913 | 11164291 | 7 | 201402 | 0 |